RTW Biotech Opportunities (LON:RTW) Stock Price Up 1.3% – Here’s Why
by Kim Johansen · The Markets DailyRTW Biotech Opportunities (LON:RTW – Get Free Report) was up 1.3% during mid-day trading on Tuesday . The company traded as high as GBX 1.55 ($0.02) and last traded at GBX 1.55 ($0.02). Approximately 761,386 shares traded hands during mid-day trading, an increase of 56% from the average daily volume of 488,407 shares. The stock had previously closed at GBX 1.53 ($0.02).
RTW Biotech Opportunities Price Performance
The stock has a market capitalization of £5.24 million, a price-to-earnings ratio of 4.33 and a beta of 0.60. The stock’s 50 day simple moving average is GBX 1.55 and its 200-day simple moving average is GBX 1.46.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Read More
- Five stocks we like better than RTW Biotech Opportunities
- What is the NASDAQ Stock Exchange?
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- What is the S&P 500 and How It is Distinct from Other Indexes
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Small-Cap Stocks Ready to Deliver Significant Growth